(Q33392815)

26 July 2017

title

Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome (English)

1 reference

26 July 2017

Clinical spectrum, pathophysiology and treatment of the Wiskott–Aldrich syndrome (English)

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

26 August 2024

main subject

Wiskott-Aldrich syndrome

0 references

1 reference

3

Hans D Ochs

1 reference

26 July 2017

2

Luigi D Notarangelo

1 reference

26 July 2017

Michael H. Albert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21076297

26 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21076297

26 August 2024

publication date

1 January 2011

1 reference

full work available at URL

26 July 2017

https://journals.lww.com/10.1097/MOH.0b013e32834114bc

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Current Opinion in Hematology

26 August 2024

published in

1 reference

26 July 2017

volume

18

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

42-48

1 reference

A multiinstitutional survey of the Wiskott-Aldrich syndrome.

26 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Isolation of a novel gene mutated in Wiskott-Aldrich syndrome

26 August 2024

2

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene

26 August 2024

3

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options

26 August 2024

5

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Clinical course of patients with WASP gene mutations

26 August 2024

6

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation

26 August 2024

7

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

The genotype of the original Wiskott phenotype

26 August 2024

8

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

FAMILIAL SEX-LINKED THROMBOCYTOPENIA.

26 August 2024

9

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia

26 August 2024

10

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia

26 August 2024

11

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene.

26 August 2024

12

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia

26 August 2024

13

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes

26 August 2024

14

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

A congenital activating mutant of WASp causes altered plasma membrane topography and adhesion under flow in lymphocytes

26 August 2024

15

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation.

26 August 2024

16

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome

26 August 2024

18

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function

26 August 2024

19

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation

26 August 2024

20

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response

26 August 2024

21

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome.

26 August 2024

22

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function

26 August 2024

23

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis

26 August 2024

24

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect

26 August 2024

25

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses

26 August 2024

26

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state

26 August 2024

27

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function.

26 August 2024

28

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells

26 August 2024

29

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

WASP: a key immunological multitasker

26 August 2024

30

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome

26 August 2024

31

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

WASP is involved in proliferation and differentiation of human haemopoietic progenitors in vitro.

26 August 2024

34

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Antiplatelet antibodies in WASP(-) mice correlate with evidence of increased in vivo platelet consumption

26 August 2024

35

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott‐Aldrich syndrome

26 August 2024

36

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome

26 August 2024

37

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets

26 August 2024

39

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

WASP plays a novel role in regulating platelet responses dependent on alphaIIbbeta3 integrin outside-in signalling

26 August 2024

40

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

The thrombocytopenia of WAS: a familial form of ITP?

26 August 2024

41

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells

26 August 2024

42

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells

26 August 2024

43

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis

26 August 2024

44

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein

26 August 2024

45

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells

26 August 2024

46

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program

26 August 2024

47

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan

26 August 2024

48

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation

26 August 2024

49

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation

26 August 2024

50

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?

26 August 2024

51

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors

26 August 2024

52

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Progress and prospects: gene therapy for inherited immunodeficiencies

26 August 2024

53

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models

26 August 2024

54

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Preventing and exploiting the oncogenic potential of integrating gene vectors

26 August 2024

55

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome

26 August 2024

56

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome

26 August 2024

57

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E32834114BC

26 August 2024

Identifiers

1 reference

26 July 2017

1 reference